Cargando…

Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: a single centre analysis of toxicity and clinical outcome

OBJECTIVES: The current standard of care for patients with metastatic prostate cancer (mPCa) at diagnosis is androgen deprivation therapy (ADT) with or without anti-androgen and chemotherapy. The aim of this study was to define the role of a local radiotherapy (RT) treatment in the mPCa setting. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riva, Giulia, Marvaso, Giulia, Augugliaro, Matteo, Zerini, Dario, Fodor, Cristiana, Musi, Gennaro, De Cobelli, Ottavio, Orecchia, Roberto, Jereczek-Fossa, Barbara Alicja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718249/ https://www.ncbi.nlm.nih.gov/pubmed/29225693 http://dx.doi.org/10.3332/ecancer.2017.786

Ejemplares similares

Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
por: Marvaso, Giulia, et al.
Publicado: (2022)

Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)
por: Marvaso, Giulia, et al.
Publicado: (2019)

Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches
por: Marvaso, Giulia, et al.
Publicado: (2021)

Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies
por: Marvaso, Giulia, et al.
Publicado: (2021)

Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review
por: Corrao, Giulia, et al.
Publicado: (2021)

Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
por: Marvaso, Giulia, et al.
Publicado: (2021)

The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases. A case report
por: Belmonte, Maddalena, et al.
Publicado: (2021)

Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone
por: Mistretta, Francesco A., et al.
Publicado: (2022)

Salvage high-dose-rate interstitial brachytherapy for perineal recurrence of prostate cancer after surgery and radiotherapy: a case report
por: Vavassori, Andrea, et al.
Publicado: (2020)

Comparison of automated segmentation techniques for magnetic resonance images of the prostate
por: Isaksson, Lars Johannes, et al.
Publicado: (2023)

Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience
por: Gerardi, Marianna A., et al.
Publicado: (2016)

Intraprostatic fiducial markers: a potential application for ultrasound-guided radiotherapy in prostate cancer
por: Vavassori, A, et al.
Publicado: (2009)

A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
por: Marvaso, Giulia, et al.
Publicado: (2023)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

Cyberknife Radiosurgery for Prostate Cancer after Abdominoperineal Resection (CYRANO): The Combined Computer Tomography and Electromagnetic Navigation Guided Transperineal Fiducial Markers Implantation Technique
por: Vavassori, Andrea, et al.
Publicado: (2023)

Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer
por: Piccinelli, Mattia Luca, et al.
Publicado: (2022)

Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy
por: Isaksson, Lars J., et al.
Publicado: (2020)

Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients
por: Alessi, Sarah, et al.
Publicado: (2019)

Combination of dabrafenib and radiotherapy: could skin toxicity be affected by different irradiation techniques?
por: Alterio, Daniela, et al.
Publicado: (2016)

Upfront Advanced Radiotherapy and New Drugs for NSCLC Patients with Synchronous Brain Metastases: Is the Juice Worth the Squeeze? A Real-World Analysis from Lombardy, Italy
por: Corrao, Giulia, et al.
Publicado: (2023)

Life style and interaction with microbiota in prostate cancer patients undergoing radiotherapy: study protocol for a randomized controlled trial
por: Gnagnarella, Patrizia, et al.
Publicado: (2022)

Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma
por: Vavassori, Andrea, et al.
Publicado: (2019)

Investigating Nutritional and Inflammatory Status as Predictive Biomarkers in Oligoreccurent Prostate Cancer—A RADIOSA Trial Preliminary Analysis
por: Zaffaroni, Mattia, et al.
Publicado: (2023)

The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis
por: Cheng, Bisheng, et al.
Publicado: (2021)

Automatic Segmentation with Deep Learning in Radiotherapy
por: Isaksson, Lars Johannes, et al.
Publicado: (2023)

High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study
por: Vavassori, Andrea, et al.
Publicado: (2019)

A Qualitative Investigation on Patient Empowerment in Prostate Cancer
por: Renzi, Chiara, et al.
Publicado: (2017)

Proton Beam Therapy in the Oligometastatic/Oligorecurrent Setting: Is There a Role? A Literature Review
por: Gaito, Simona, et al.
Publicado: (2023)

Quality assurance for automatically generated contours with additional deep learning
por: Isaksson, Lars Johannes, et al.
Publicado: (2022)

Anterior prostatic tumours are difficult to diagnose without MRI
por: Petralia, Giuseppe, et al.
Publicado: (2012)

COVID-19 impact in radiotherapy practice in an oncology hub: a screenshot from Lombardy, Italy
por: Corrao, Giulia, et al.
Publicado: (2020)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
por: Chaloupka, Michael, et al.
Publicado: (2021)

Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
por: Zaffaroni, Mattia, et al.
Publicado: (2022)

COVID-19 manifestation in the oral cavity – a narrative literature review
por: Kusiak, Aida, et al.
Publicado: (2021)

Radiotherapy of oligometastatic prostate cancer: a systematic review
por: Rogowski, Paul, et al.
Publicado: (2021)

Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis
por: Chung, Doo Yong, et al.
Publicado: (2023)

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml
por: Ferro, Matteo, et al.
Publicado: (2013)

Association between Alcohol Intake and Prostate Cancer Mortality and Survival
por: D’Ecclesiis, Oriana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jjjmc67vdsce32njauhtrpdcbc